Comparator Drugs - Procurement Best Practices & Sourcing Strategies
Home / Procurement Intelligence / Pharma R&D / Comparator Drugs

Procurement Market Intelligence Report

Comparator Drugs – Procurement Best Practices & Sourcing Strategies

Comparator Drugs Market – Executive Summary/COVID-19 Update, Market Analysis, Cost Drivers and Cost Structure, Market Monitoring Insights, Sourcing Practices, Sustainability, Supplier Section, Innovation Platforms

1. Executive Summary/COVID-19 Update
1.1. Executive Summary
1.2. COVID Impact Update
2. Market Analysis
2.1. Global Market Size and Growth Forecast
2.2. Growth Drivers & Constraints
2.3. Market Trends
2.4. Regulatory Trends
2.5. Porter’s Five Forces Analysis
2.6. Outsourcing Trends
2.7. Regional Analysis
3. Cost Drivers and Cost Structure
3.1. Cost Drivers and Cost Structure
4. Market Monitoring Insights
4.1. Billing Rates Overview
4.2. Comparator Sourcing -Billing Rates
4.3. Billing Rates: Benchmarking
4.4. Factors Influencing Comparator Sourcing Billing Rate
5. Sourcing Practices
5.1. Engagement and Pricing Model
5.2. Purchase Process
6. Sustainability
6.1. Sustainability in Comparator Drugs
7. Supplier Section
7.1. Key Suppliers
Supplier List and Capabilities
7.2. Key Global Supplier Profile
7.3. Key Global Supplier: SWOT
8. Innovation Platforms
8.1. Innovations in Comparator Drugs

Additional Information

Purchase Option

Multiple User License, Single User License

Quantity

Related Products

Shopping Basket